Irradiating the Subventricular Zone in Glioblastoma Patients: Is there a Case for a Clinical Trial?. Issue 1 (January 2017)

• Record Type: Journal Article
• Authors: Nourallah, B.; Digpal, R.; Jena, R.; Watts, C.
• Is Part Of: Clinical oncology. Volume 29:Issue 1(2017)
• Page Start: 26
• Page End: 33
• Publication Date: 2017-01
• Subjects: Cancer stem cells -- glioblastoma -- neural stem cells -- radiotherapy -- subventricular zone; Oncology -- Periodicals; Tumors -- Periodicals; Cancer -- Treatment -- Periodicals; Radiotherapy -- Periodicals; Neoplasms -- Periodicals; Cancer -- Radiotherapy; Cancer -- Treatment; Oncology; Medical radiology; Radiotherapy; Tumors; Electronic journals; Periodicals; 616.994
• DOI: 10.1016/j.clon.2016.09.005
• Languages: English
• ISSNs: 0936-6555

Abstract

Abstract: Glioblastoma is the most common and aggressive adult brain tumour. Over the last 10 years it has emerged that the subventricular zone (SVZ), the largest adult neural stem cell niche, has an important role in the disease. Converging evidence has implicated transformation of adult neural stems in gliomagenesis and the permissive stem cell niche in disease recurrence. Concurrently, clinical studies have suggested that SVZ involvement is a negative prognostic marker. It would follow that irradiating the SVZ may improve outcomes in glioblastoma by directly targeting this putative sanctuary site. To investigate this potential strategy, 11 retrospective studies and 1 prospective study examined the relationship between dose to the SVZ and survival outcomes in glioblastoma patients. This review summarises the theoretical underpinning of this strategy, provides a critical evaluation of the existing evidence and discusses the rationale for a clinical trial.